B-FOLCIN

Quick links

Choose a section

Quick links to important sections

Advertisements

B-FOLCIN

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of B-FOLCIN

Property Description
Active Ingredients Folic Acid, Niacinamide, Riboflavin
Form Oral tablet preparation
Pharmacological Class Multivitamin preparation (B-group vitamin complex)
Common Use Nutritional support for B-vitamin deficiencies
Origin Primarily synthetic compounds

B-FOLCIN is a combination drug designated as a multivitamin preparation within the B-group vitamin complex, primarily supplied as an oral preparation in a tablet form. This formulation provides a synchronized source of three distinct, essential nutrients intended to support core metabolic functions. The product’s classification as a combination drug differentiates it from single-vitamin supplements, offering a multi-component therapeutic strategy for managing simultaneous B-vitamin depletion.

Composition: Active Ingredients and Origin

The identity of B-FOLCIN is defined by its three active ingredients [INN]: Folic Acid (Vitamin B₉), Niacinamide (Vitamin B₃), and Riboflavin (Vitamin B₂). The inclusion of Folic Acid is critical because its biologically active forms are essential for nucleotide biosynthesis and the formation of red blood cells. Niacinamide and Riboflavin, which are typically produced through synthetic means, are included as direct coenzyme precursors for cellular respiration and energy metabolism.

General Purpose: Nutritional Support and Cellular Balance

The overarching purpose of B-FOLCIN is to provide targeted nutritional support aimed at preventing or correcting deficiency states linked to insufficient intake or malabsorption. B-complex vitamins support normal nervous system function and the maintenance of healthy mucous membranes, reinforcing the foundational physiological role of these nutrients. By supplying these essential metabolic cofactors, the formulation supports the maintenance of overall physiological balance, aids in DNA synthesis regulation, and sustains efficient cellular function, making it a typical choice for individuals with chronic dietary insufficiency.

Regulatory References

  1. NIH Office of Dietary Supplements
  2. MedlinePlus, National Library of Medicine
Advertisements

What side effects are possible with B-FOLCIN?

Possible side effects and safety information

The safety profile of B-FOLCIN, a multivitamin preparation containing Folic Acid (Vitamin B₉), Niacinamide (Vitamin B₃), and Riboflavin (Vitamin B₂), is based on regulatory classifications of adverse reactions documented in official prescribing information.

Adverse reactions are grouped by their frequency and the body system affected (System-Organ Classes), ranging from common, expected events to rare, serious reactions.


Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects
Common Headache; Gastrointestinal complaints (e.g., nausea, mild abdominal discomfort); Transient cutaneous flushing (related to Niacinamide).
Uncommon Skin rash; Pruritus (itching).
Rare Severe hypersensitivity reactions, including Anaphylactic shock and Angioedema.

System-Organ Classes and Key Safety Notes

The official labeling notes effects primarily within Immune System Disorders, Gastrointestinal Disorders, and Skin and Subcutaneous Tissue Disorders. A non-pathological, expected safety characteristic is the yellow-orange discoloration of urine (chromaturia), which occurs due to the excretion of Riboflavin, categorized under Renal and Urinary Disorders.

Official safety notes document that the severity of flushing may be dose-dependent and that the administration of Folic Acid carries a risk of masking the hematological signs of Vitamin B₁₂ deficiency (pernicious anemia), which can allow related neurological damage to continue unchecked. The medicine is contraindicated in individuals with known hypersensitivity to any of the active components.

Advertisements

Overdose and Emergency Response

Official regulatory information for B-FOLCIN dictates that a suspected overdose requires immediate medical attention. You must seek immediate medical attention or contact a Poison Control center for any exposure exceeding the recommended dose. The need for urgent help is based on the potential for severe systemic risks.

Documented presentations of overdose are primarily associated with gastrointestinal upset, including nausea, vomiting, and abdominal pain. Dermatological reactions, such as flushing and pruritus, are also commonly reported, alongside CNS effects like headaches, confusion, and irritability.

The most serious potential risks stem from toxic levels of Niacinamide, which may lead to hepatotoxicity, acute liver failure, and significant cardiovascular abnormalities such as arrhythmias and hypotension. No specific antidote is known, and treatment is symptomatic and supportive. Required procedural interventions often include continuous ECG monitoring and laboratory monitoring of liver function and blood clotting factors. Furthermore, regulatory documents specify a unique neurological risk: high-dose Folic Acid can mask the neurological signs of pernicious anemia, allowing for the progression of severe nervous system damage.

Advertisements

Therapeutic Uses of B-FOLCIN

What B-FOLCIN Treats: Main Uses and Benefits

B-FOLCIN is commonly used to help manage symptoms associated with deficiencies in Folic Acid (Vitamin B9) and Vitamin B12, or to provide nutritional support. The medication is applied in clinical settings that involve systemic imbalance.

This medication is generally used to help with managing symptoms related to physical discomfort and functional strain. The therapeutic benefit includes addressing symptom clusters that may become intense, such as painful mouth sores, a sore or red tongue, and persistent fatigue or weakness. It is relevant in conditions characterized by periods of heightened symptoms and is applied across domains where additional symptomatic support is needed.

Quick Fact: Relief for Deficiency Symptoms

B-FOLCIN supports patients by easing the overall symptom burden when discomfort may be linked to B-vitamin deficiencies, which can affect daily stability.

Supportive Use for Increased Nutritional Needs

The use of B-FOLCIN is considered relevant in conditions where the body’s need for these vitamins is increased or where absorption may be impaired, such as during pregnancy or certain gastrointestinal disorders. It provides necessary supportive supplementation to help address potential deficiency-related symptoms and supports essential bodily functions. This application may assist with maintaining functional stability when symptoms interfere with routine activities.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use B-FOLCIN? (Official Regulatory Information)

Official regulatory documents define specific populations who must not use this medicine due to safety concerns. This includes individuals with a documented hypersensitivity or allergy to any component of B-FOLCIN, which typically includes Folic Acid, Niacinamide, and Riboflavin.

The most critical restriction is the contraindication in patients with untreated or undiagnosed Vitamin B12 deficiency, such as pernicious anemia. Using folic acid alone in these conditions can prevent the hematological symptoms from appearing while irreversible neurological damage continues, a clinical phenomenon often referred to as 'masking.' Therefore, the cause of anemia must be definitively established before starting treatment.

Contraindicated and Restricted Use Populations

Classification Populations/Conditions
Contraindicated (Must not use) Known hypersensitivity to any component; Untreated Vitamin B12 deficiency (e.g., pernicious anemia); Malignant disease (unless a co-existing folate deficiency is a key complication).
Special Consideration/Caution Patients with active liver disease; Patients with peptic ulcer disease; Patients with Leber's Disease; Severe renal impairment (requires caution and careful monitoring).

Use is generally not recommended in pregnant or breastfeeding women unless the need is clearly established by a healthcare professional.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions with B-FOLCIN are primarily driven by the Folic Acid component, which can affect the action of other drugs or have its own absorption and effects altered by co-administered substances.

Clinically Significant Interactions

Interacting Medicine Category Mechanism & Constraint
Anticonvulsants (e.g., Phenytoin, Phenobarbital, Primidone) Folic acid may reduce serum levels of these drugs, necessitating careful physician monitoring and potential dose adjustment to maintain therapeutic efficacy.
Antifolate Medicines (e.g., Methotrexate, Trimethoprim) These drugs reduce the effect of folic acid, as they antagonize its action.
Fluorouracil Co-administration is generally avoided due to the potential for increased toxicity of Fluorouracil.

Altered Absorption and Timing Constraints

  • Sulfasalazine and certain antibiotics (e.g., sulfonamides) may reduce the effectiveness of folic acid.
  • Antacids containing aluminium or magnesium, and Cholestyramine, can reduce the absorption of folic acid.
  • For Cholestyramine, Folic Acid should be taken 1 hour before or 4 to 6 hours after the treatment.
  • Antacids should be taken at least two hours after Folic Acid administration.

Other Interactions

  • Caution is advised in patients who may have folate-dependent tumours.
  • Folic acid may reduce the intestinal absorption of zinc, which is particularly relevant during pregnancy.
Advertisements

Mechanism of Action

Mechanism of Action: Cofactor Restoration and Metabolic Flux

B-FOLCIN exerts its effect through cofactor supplementation, providing the necessary coenzymes ( B9, B12, B6) required for core metabolic pathways. The active forms, such as methylcobalamin and methyltetrahydrofolate, act synergistically to sustain the activity of Methionine Synthase (MTR), restoring the flux of the one-carbon metabolism cycle. This interaction is not inhibitory, but rather facilitates enzymatic turnover by supplying necessary substrates and cofactors.

The mechanistic cascade has two main consequences: First, the sustained cycle enables the conversion and metabolic clearance of the amino acid homocysteine via MTR and the B6-dependent transsulfuration pathway. Second, the regeneration of free folate cofactors supports the de novo synthesis of purine and thymidylate for DNA replication.

At a systemic level, this intracellular support dictates the speed and fidelity of hematopoietic cell division, influencing the maturation and morphology of red blood cell precursors. The availability of SAM (a product of the cycle) is further critical for methylation processes, impacting neuronal structures and influencing vascular endothelium by reducing the circulating load of homocysteine.

Advertisements

Dosage and Administration Information

Administration of B-FOLCIN

B-FOLCIN (Folic Acid) is a B vitamin prescribed for the treatment of megaloblastic anemias due to folate deficiency. Administration is most commonly Oral using tablets, but the injectable solution allows for Intravenous (IV), Intramuscular (IM), or Subcutaneous (SC) injection when oral administration is not feasible or malabsorption is present.

Dosing and Timing

Patient Group Usual Therapeutic Dosage Maintenance Dosage Frequency
Adults Up to 1 mg daily 0.4 mg daily Once Daily
Children (4+ years) Up to 1 mg daily 0.4 mg daily Once Daily
Pregnant/Lactating — 0.8 mg daily Once Daily
Infants — 0.1 mg daily Once Daily

Oral doses can be taken with or without food. Maintenance dosing begins after clinical symptoms subside and the blood picture normalizes. Certain conditions like chronic infection, alcoholism, or pregnancy may require the maintenance dose to be at least doubled.

Procedural and Safety Steps

The most crucial procedural instruction is that doses greater than 0.1 mg daily must not be used unless a concurrent Vitamin B12 deficiency (e.g., pernicious anemia) has been ruled out or is being adequately treated with cobalamin. Folic acid alone can mask the blood-related symptoms of B12 deficiency while allowing irreversible neurological damage to progress. If an oral dose is missed, do not double the next dose; simply skip the missed dose and resume the regular daily schedule. Injectable forms, especially those containing benzyl alcohol, are typically contraindicated in infants.

Advertisements

Recent Clinical Evidence

Evidence for B-Vitamin Deficiency States

The research base for B-FOLCIN summarizes foundational evidence, including Randomized Controlled Trials (RCTs) and Systematic Reviews, that have examined the component vitamins and monitored changes in established deficiency states and associated symptom patterns. Research on the vitamins contained in B-FOLCIN was studied for its use in exploring outcomes related to classic deficiency syndromes involving Folic Acid, Niacinamide, and Riboflavin, focusing on adults with chronic dietary insufficiency.

Research primarily examined outcomes related to physiological strain or stress, such as measurement of biochemical deficiency biomarkers (including specific red blood cell indices). Studies also explored patient-reported outcomes describing perceived discomfort and shifts in symptom clusters often associated with deficiency, such as persistent fatigue or oral issues. Foundational studies report how symptoms evolved in the observed populations and contribute to understanding symptom patterns within the broader research landscape.


Supportive Use and Special Populations

The evidence also includes Observational Studies and Meta-analyses that was studied for the use of B-FOLCIN's components in specific risk groups, such as pregnant individuals or patients with certain gastrointestinal disorders where nutrient absorption may be limited. Research explored outcomes reflecting daily functioning or activity level in these special populations. Follow-up durations were limited in some trials, and while research provides insight into short-term changes, long-term effects are not fully established specifically for the combination. Data for certain groups remain insufficient, and subgroup findings are uncertain.


Key Limitations and Uncertainty

A key limitation is that the extensive evidence base was studied for the three component vitamins individually, meaning comparative evidence is lacking for the specific B-FOLCIN combination itself when assessed against single-vitamin treatments. Research is ongoing to better contextualize the role of combination supplements in varied patient populations.

Key Studies & References

  1. NIH Office of Dietary Supplements—Folate Fact Sheet for Health Professionals
  2. MedlinePlus (National Library of Medicine)—B Vitamins: General Overview of Deficiency Symptoms
Advertisements

Frequently Asked Questions (FAQ)

Common questions about B-FOLCIN (FAQ)

Q: What is the main difference between B-FOLCIN and regular folic acid supplements?

B-FOLCIN is officially classified as a multivitamin preparation because it contains a combination of three active ingredients: Folic Acid, Niacinamide (Vitamin B₃), and Riboflavin (Vitamin B₂). A regular folic acid supplement typically contains only Folic Acid. The combination is intended to address deficiencies of multiple B-group vitamins simultaneously.

Q: Why is B-FOLCIN sometimes prescribed with other vitamins?

As a multivitamin preparation, B-FOLCIN is described in official documents as providing targeted nutritional support aimed at correcting deficiency states that may involve multiple B-group vitamins simultaneously. Official information indicates that the combined ingredients support core metabolic pathways and cellular function.

Q: Is B-FOLCIN considered a vitamin, a medicine, or something else?

Official documents classify B-FOLCIN as a multivitamin preparation within the B-group vitamin complex. It is prescribed for the treatment of megaloblastic anemias and other B-vitamin deficiency states, meaning it is a pharmaceutical product used therapeutically under medical guidance.

Q: How long does it usually take before a person notices any change from taking B-FOLCIN?

Regulatory summaries note that the time until a noticeable change can vary by individual. Research on the vitamin components often monitors short-term changes in biochemical markers, such as specific red blood cell indices. As with any deficiency treatment, the timeline for physiological change can vary by individual, and long-term effects for the specific combination are noted as not fully established.

Q: Can B-FOLCIN be used for general 'wellness' or health maintenance?

The official documentation defines the product’s common use as Nutritional support for B-vitamin deficiencies and the treatment of specific anemias. Its approved indications are focused on correcting or preventing established deficiency states, rather than general, non-specific nutritional support.

Q: Are there any common foods or drinks that should be avoided while taking B-FOLCIN?

Official drug labels list potential interactions with other medicines and supplements. However, they generally do not list specific common foods or drinks that must be avoided. The official guidelines state that the oral form of the medicine can typically be taken with or without food.

Q: Is there a maximum amount of time B-FOLCIN is usually prescribed for?

The official product information distinguishes between a higher Therapeutic Dosage used to actively correct a deficiency and a lower Maintenance Dosage used after initial symptoms improve. Maintenance dosing may be required for chronic conditions, but there is no universal single maximum duration stated in official guidelines.

Q: Can people who are allergic to certain vitamins still use B-FOLCIN?

No. Official documents state that the medicine is contraindicated (must not be used) in individuals with a known hypersensitivity or allergy to any component of B-FOLCIN. This includes any of its active ingredients: Folic Acid, Niacinamide, or Riboflavin.

Q: Are there different versions or strengths of B-FOLCIN available?

B-FOLCIN is primarily available in a specific oral tablet preparation. Official product information also mentions an injectable solution for patients when oral administration is not possible. There are different established daily doses listed for various populations, such as adults and children.

Q: Is B-FOLCIN mentioned in research studies related to heart health?

The official mechanism of action describes that the components support the metabolic clearance of the amino acid homocysteine. Elevated homocysteine is a factor studied in vascular research. Therefore, studies have examined this pathway, which is related to cardiovascular outcomes.

Q: What is the connection between B-FOLCIN and specific genetic variations?

The Folic Acid component must be converted into active forms (like methyltetrahydrofolate) to function. Authoritative sources describe how genetic variations in certain enzymes, such as MTHFR, can affect a person's ability to process folate, which can be a factor in determining the necessary nutritional support.

Q: Does B-FOLCIN have any known interactions with herbal supplements?

Regulatory documents generally advise caution regarding co-administration of folic acid with other supplements. Folic acid may specifically reduce the intestinal absorption of zinc, which is an ingredient found in some supplements. Users are generally advised to inform a healthcare provider about all current supplements being taken.

Q: How is the purpose of B-FOLCIN explained in patient information leaflets?

Patient information generally explains the purpose as providing targeted nutritional support for B-vitamin deficiencies, aiding in DNA synthesis regulation, and sustaining efficient cellular function by providing essential metabolic cofactors.

Q: Why do some people say B-FOLCIN gives them mild stomach upset?

The official safety profiles document Gastrointestinal complaints as a Common adverse reaction. These commonly documented effects include reports of nausea and mild abdominal discomfort.

Q: Is it true that B-FOLCIN is sometimes used to help with certain skin conditions?

Official information regarding B-complex vitamins consistently affirms their role in supporting normal function, including maintaining healthy mucous membranes and skin. The official purpose is to correct deficiency states where a lack of these vitamins could negatively affect such areas.

Q: Does B-FOLCIN affect the results of any common lab tests?

Official warnings document that the Folic Acid component carries a risk of masking the hematological signs of Vitamin B₁₂ deficiency during diagnosis. This can prevent the detection of related neurological damage. Therefore, the medicine should be avoided during the diagnostic testing for this specific disorder.

Q: Is there evidence of B-FOLCIN research being done in children?

The official dosing table includes established doses for both Children (4+ years) and Infants, indicating its use in pediatric populations is documented and authorized. However, the evidence section specifically discussing clinical trials for the combination product mostly refers to studies in adults.

Q: Does B-FOLCIN contain any ingredients that are common allergens?

The medicine is contraindicated in individuals with a known hypersensitivity to its active ingredients (Folic Acid, Niacinamide, and Riboflavin). These components are recognized in official labeling as substances that carry a risk of allergic reaction.

Q: How quickly does B-FOLCIN leave the body after you stop taking it?

Official information confirms that B-FOLCIN contains Riboflavin, which is rapidly excreted from the body, causing a noticeable yellow-orange discoloration of urine. Since B-vitamins are water-soluble, they are generally not stored in large amounts and are continuously processed and excreted by the body.

Q: What is the difference between B-FOLCIN and products that contain just methylfolate?

B-FOLCIN contains Folic Acid, which is an inactive form that must be converted by the body into the active form (like methyltetrahydrofolate). Products with just methylfolate already provide this active form. B-FOLCIN is also a combination product containing two other B-vitamins, Niacinamide and Riboflavin.

Q: Is B-FOLCIN associated with any sleep disturbances?

Official safety profiles list side effects grouped by body system, such as Immune System, Gastrointestinal, and Skin. The prescribing information does not list sleep disturbances or insomnia among the common, uncommon, or rare adverse effects documented for the medicine.

Q: Is the effect of B-FOLCIN consistent across different patient groups?

Regulatory summaries of evidence note that research data for certain patient groups remain insufficient, and findings for specific subgroups are sometimes uncertain. Use in risk groups, such as those with gastrointestinal disorders, is mentioned as requiring special consideration to ensure consistent effect.

Q: Does B-FOLCIN need to be taken at a specific time of day to work best?

Official administration guidelines for the oral dose do not specify a time of day when the medicine must be taken. The guidelines only state that oral doses can be taken with or without food.

Q: Why is B-FOLCIN described as a 'pro-drug' in some places?

The mechanism of action describes that the Folic Acid component must be converted into active coenzymes, such as methyltetrahydrofolate, before it can fully function in the body. The need for this conversion process is the basis for some sources describing the Folic Acid component as a 'pro-drug'.

Q: Does B-FOLCIN have an expiration date, and is it still effective after it passes?

Official guidance mentions that expired B-FOLCIN must be handled as pharmaceutical waste, which confirms that the product does have a defined lifespan to maintain stability and effectiveness. Medicines are not recommended for use after the expiration date listed on the packaging.

Q: What kind of side effects are most often mentioned by users of B-FOLCIN?

The official safety profile lists Common adverse reactions, which are the ones most frequently documented. These commonly reported effects include headache, gastrointestinal complaints such as nausea or mild abdominal discomfort, and a transient cutaneous flushing (related to Niacinamide).

Q: Is it safe to take B-FOLCIN if I also take blood thinners?

The interaction section advises caution and monitoring for potential interactions with certain drugs. Official guidance notes that users are advised to inform their healthcare professional of all current medications, including any blood thinners, as interactions may require monitoring.

Q: Does B-FOLCIN interact with common pain relievers like ibuprofen?

The official product information lists interactions with several medicine categories, but common non-prescription pain relievers like ibuprofen are not explicitly listed in the clinically significant interaction warnings. Official guidance suggests informing a healthcare provider about all medicines being taken to ensure comprehensive care.

Q: What happens if someone accidentally misses a dose of B-FOLCIN?

The procedural instructions in the official guidelines state that if an oral dose is missed, the user must not double the next dose. Instead, the person should simply skip the missed dose and resume the regular daily schedule.

Q: Why is it important to tell your doctor about other medicines when starting B-FOLCIN?

It is important because the components of B-FOLCIN may affect the action of other drugs, such as potentially reducing the serum levels of certain anticonvulsants. Disclosing all medications ensures the physician can monitor effects and make necessary adjustments to maintain the effectiveness and safety of all treatments.

Q: Can B-FOLCIN be taken by someone with diabetes?

The official document lists specific conditions that require caution or where use is contraindicated, such as untreated Vitamin B12 deficiency or active liver disease. Diabetes is not listed among these specific conditions, but any underlying chronic condition is typically a topic for discussion with a healthcare provider.

Q: Are there any common reasons why a doctor might decide to stop a patient's B-FOLCIN treatment?

Reasons for cessation or change are typically based on conditions like the development of a hypersensitivity or the full correction of the initial deficiency that the medicine was treating. The formal Therapeutic Dosage is usually stopped and transitioned to a lower Maintenance Dosage once the blood picture normalizes.

Advertisements

How should B-FOLCIN be stored and disposed of?

How to Store and Dispose of B-FOLCIN?

The storage and disposal of B-FOLCIN tablets must strictly follow the conditions specified in regulatory labeling to maintain product stability and ensure safety.

Storage Requirement Instruction
Temperature Do not store above 25 C (77F). Do not refrigerate or freeze.
Protection Keep in the original container and protect from moisture and light.
Safety The medicine must be kept out of the sight and reach of children.

Unused or expired B-FOLCIN must be handled as pharmaceutical waste. Disposal must be done in accordance with local requirements. Regulatory guidance specifies that the product must not be thrown into household waste or discarded via wastewater, which helps prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of B-FOLCIN found in:

A-Z Index: